All In MedTech

Device Trial Radar · NCT04171479

RMN Versus Manual Epicardial Retrospective PMCF

A Retrospective Multicenter Post-Market Clinical Follow-up Registry Comparing Safety and Effectiveness Outcomes of Epicardial Cardiac Ablation Using Remote Navigation to Manual Techniques

Last checked: Nov 20, 2026Latest source record: Aug 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Oct 2, 2020

Primary completion

Mar 30, 2023

Study completion Mar 30, 2023

Sponsor

Lead sponsor
StereotaxisPublic (STXS)
Sponsor type
Industry
First posted
Nov 21, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

Retrospective registry will compare subjects who've undergone a mapping and/or ablation procedure for either ischemic ventricular tachycardia or premature ventricular contraction using an epicardial approach with either manual or remote magnetic navigation. Subjects will be compared with regards to safety, efficacy and mortality.

Conditions

  • Ventricular Tachycardia
  • Premature Ventricular Contraction

Interventions

  • Epicardial mapping and/or ablationDevice

    Either catheter mapping, ablation, or mapping and ablation will be performed using an epicardial catheter approach.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Acute SuccessTime frame: intra-operative
  2. Procedural Safety: rates of device-and procedure-related serious adverse eventsTime frame: 48 hours post index procedure

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Na Homolce Hospital

    Prague, Czechia

  • OLVG Hospital

    Amsterdam, Netherlands

  • Erasmus Medical Center

    Rotterdam, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.